Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Gastrointestinal 1

Conditions

Multiple Myeloma 26Neoplasms, Plasma Cell 20Lymphoma 16Neuroblastoma 12Neoplasm Metastasis 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia, Myeloid, Acute 7Sarcoma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Leukemia 6Colorectal Neoplasms 6Rectal Neoplasms 5Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Colonic Neoplasms 5Liver Neoplasms 4Immunoglobulin Light-chain Amyloidosis 4Hodgkin Disease 4Burkitt Lymphoma 4Recurrence 3Neuroectodermal Tumors, Primitive, Peripheral 3Neoplasms 3Melanoma 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hyperthermia 3Hematologic Neoplasms 3

Interventions

Melphalan 3sargramostim 1romidepsin 1montanide ISA 51 1keyhole-limpet hemocyanin 1detox adjuvant 1Waiting Lists 1Thalidomide 1Radiosurgery 1Radiation 1Leucovorin 1Ketoconazole 1Interleukin-2 1Floxuridine 1FANG vaccine 1Docetaxel 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Genetic Diseases, Inborn × Melphalan × Clear all
NCT00019097 2024-03-04

Vaccine Therapy in Treating Patients With Multiple Myeloma

National Cancer Institute (NCI)

Phase 2 Completed
Other hematologic neoplasmPlasma cell

Multiple Myeloma, Neoplasms, Hematologic Neoplasms, Genetic Diseases, Inborn, Neoplasms, Plasma Cell

NCT00019760 2023-10-31

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Genetic Diseases, Inborn

NCT00017680 2008-06-09

Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis

Office of Rare Diseases (ORD)

Phase 2 Completed
25 enrolled
Other hematologic neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Arthritis, Connective Tissue Diseases, Hematologic Neoplasms, Genetic Diseases, Inborn, Rare Diseases, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡